According to a research report published by Spearhead Acuity Business Research, the blood monitoring and cardiac monitoring market in Latin America is majorly dominated by local players because the science and technology behind the devices is relatively mature. However, the environmental and health regulations are now compelling companies to shift their focus towards developing devices lacking mercury. The global market for blood monitoring and cardiac monitoring devices reported revenue worth USD 17,770 million in 2014 and is expected to grow at a CAGR of 6.8% to reach USD 24,830.1 million by 2019. North America is currently leading the global market with 36.4% market share in 2014 due to the presence of major manufacturers and extensive research and development activities. The global market is highly fragmented and most of the players depend on competitive pricing for sustainable business, which further increases the level of competition.
